On the HCPLive Internal Medicine condition center page, resources on the topics of medical news and expert insight into internal medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on internal medicine research, treatment, and drug development.
February 4th 2023
The sBLA for lanadelumab permits its use as a prophylaxis in children as young as 2 years old with the rare condition.
20-Year Study Finds Cancer Mortality On The Rise People with Type 2 Diabetes
January 25th 2023An analysis of 2 decades worth of data from the Clinical Practice Research Datalink suggests all-cause mortality rates in type 2 diabetes have decreased but sheds light on upward trends in mortality from multiple different forms of cancer, including pancreatic, liver, and lung cancer, particularly among older patients.
COVID-19 Pandemic May Have Worsened Racial Disparities in Wait Times for Specialty Consults
January 23rd 2023A new study from clinicians in the VA Boston Healthcare System provides an overview of the impact the COVID-19 pandemic has had on racial disparities in wait times for new cardiology and orthopedic specialist consultations.
Phase 3 Data Support Myelodysplastic Syndromes Treatment as Potential First-in-Class Therapy
January 4th 2023Promising results from the IMerge phase 3 clinical trial met the primary and secondary endpoints in the investigation of imetelstat, a novel telomerase inhibitor developed for hematologic malignancies.
Commotio Cordis: What to Know and How to Communicate with Patients, with Jesse Morse, MD
January 3rd 2023Jesse Morse, MD, a sports medicine specialist, discusses commotio cordis and how to effectively communicate with athletes and parents of young athletes about the diagnosis in the wake of an incident where a player collapsed during a recent NFL game.
Patient-Reported Outcomes Become More Involved in Treating, Managing Rheumatic Diseases in 2022
With a great deal of marginalized patients navigating burdensome, chronic, heterogenetic disease today, rheumatologists are becoming more invested in what the individual needs and wants from care.
Building the Biomarker Panel in Neurology: Glial Fibrillary Acidic Protein
As the treatment paradigm for neurologic diseases rapidly progresses, the need for more thorough biomarker tools to measure disease progression and severity has increased. In recent years, GFAP has emerged as a valuable candidate to add to the existing panel.
Clinical Comparison of Rituximab and Cyclophosphamide for Interstitial Lung Disease (ILD-CTD)
November 28th 2022Despite its frequent use as a rescue therapy for patients with interstitial lung disease associated with connective tissue disorder, the effectiveness of rituximab hasn't been evaluated in many clinical trials.